Gevo a winner? Not the issue, says Butamax, as the Capulets and Montagues get it on again. It’s a tennis match in which the score is never love. Scene: Verona. A public place. The Prince: Three civil brawls, bred of an airy word, By thee, old Butamax, and Gevo, Have thrice disturb’d the quiet of our […]
Ah, advanced biofuels’ Montagues and Capulets are at it again, gentle reader. Two households, both alike in dignity In fair Digestville, where we lay our scenes, From ancient grudge break to new enmity, As IP woes drive civil suits re: genes. From forth the fatal loins of these two foes A pair of star-cross’d […]
In Delaware, Gevo recently won a ruling in the Butamax litigation; Butamax had filed an injunction to stop Gevo from selling its biofuels products while the patent infringement case wages on. The injunction was denied on appeal by a Federal Circuit Judge after it was originally denied earlier this year. More on the story.
In Delaware, the USPTO has granted Butamax Patent Number 8,273,558 (‘558 patent). The innovative ‘558 patent technology provides a path to commercial production volumes of biobutanol for the global biofuel and other markets. Butamax has specifically designed its microorganism to be cost-effective for all markets, but particularly for biofuel blending. While unmodified yeast may produce […]
In Delaware, Butamax has received a US patent ‘878 for its enzyme production as it pertains to the production of isobutanol. The company filed an additional lawsuit against Gevo last week for infringement upon this patent as it demonstrated that Butamax innovated the technology for isobutanol production years before Gevo patents were filed. “Butamax was […]
In Delaware, Butamax provided this latest update on the litigation activity between Butamax and Gevo related to biobutanol patents. Last week, Butamax filed suit in the U.S. District Court of Delaware for a determination that Butamax does not infringe any valid claim of the Gevo patent 8,232,089. The ‘089 patent relates to the use of […]
In Colorado, Gevo announced that it will file a motion for preliminary injunction against Butamax and DuPont to halt ongoing infringement of a Gevo patent covering the production of isobutanol with genetically engineered microorganisms. “Isobutanol is an extremely versatile molecule that can be used for production of everything from the gasoline blendstock of the future to jet […]
In Colorado, Gevo was awarded its 11th patent by the USPTO, #8,232,089 which futher enhances biobutanol production in yeast. Brett Lund, Excecutive VP and General Counsel stated the patent as another in a series that makes changes in the yeast pathway by eliminating byproducts and improving efficiency, that altogether “… enable a process efficiency exceeding […]
In Delaware, Butamax Advanced Biofuels, LLC announced that the United States Patent and Trademark Office (USPTO) has granted it Patent Number 8,222,017 which protects a subset of key enzymes in the isobutanol production pathway. This latest patent covers the subset based on KARI enzymes modified to create production efficiencies through the fundamental isobutanol biosynthetic pathway […]
In Colorado, Gevo has hit a roadblock after its victory in the Butamax litigation last month: a federal judge has ordered that Gevo hold on distributing its isobutanol into automotive fuel markets through any appeal process. The court order did not preclude Gevo from selling isobutanol into its key chemicals and aviation fuel markets, however […]
